Articles:

It includes the technology used to track the movements of a tower crane as well as highly complex design authoring software.

The good news is that there is already some strategic collaboration happening in these areas.. As many new medicines are developed by start-ups, if we can ensure good guidance and information then we can get things right from the start.There are already collaborative groupings of start-ups, and linking these with the information flow on alternatives and economics could be highly beneficial..

The group agreed that framing the driver for change around waste reduction and sustainable economics, together with greater public and business awareness and, would help to push the agenda in the right direction.. Regulators and regulations can be enablers for change, rather than inertial.The more consistent and proactive enablers, the better; they could create an environment where positive change can happen quickly within a clear, consistent economic playing field.. New technologies, including AI models to help predict the presence of harmful impurities alongside developments in impurity detection at parts per trillion levels, could be extremely useful.In conjunction with testing/development facilities, these technologies could accelerate problem finding and solving..

Fear, and the inertia of uncertainty, is lessened by shining a light on the technological and economic opportunities.This includes sharing insights from the R&D-led industry with contract manufacturers, generics and start-ups..

Start-up companies need investment to scale up quickly to support the pharmaceutical industry.

While grants can help, they are not sufficient on their own – governments and industry stakeholders must actively identify and fund promising new developments.. Keeping collaborations and conversations wide, while understanding there are solutions and opportunities still hidden away, will facilitate progress.Initial concepts can be produced using algorithmic design tools.

Detailed design outputs for manufacturing can be produced automatically.The review and approval process is simplified dramatically.

Safety related and non-safety related systems are separated and simplified.The amount of information to be reviewed is significantly reduced.